Terry A. Jacobson
Terry A. Jacobson publishes mostly in Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Fatty Acid Research and Health.
- World rank
- #35,541 of 7,710,434 ranked researchers
- Rank in United States
- #13,576 of 1,627,098
- Works
- 299
- Citations
- 28k
- Citations per work
- 93.7
What does Terry A. Jacobson research?
Terry A. Jacobson's work is mostly in Medicine (49%), Economics, Econometrics and Finance (7%), Nursing (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences17658.9%
- Medicine14548.5%
- Nursing206.6%
- Health Professions113.8%
- Everything else10133.7%
- Social Sciences227.4%
- 1Surgery27% of their works
- 2Endocrinology, Diabetes and Metabolism11% of their works
- 3Cardiology and Cardiovascular Medicine10% of their works
- 4Economics and Econometrics7% of their works
- 5Nutrition and Dietetics7% of their works
- 6General Health Professions4% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Fatty Acid Research and Health
- Health Systems, Economic Evaluations, Quality of Life
- Cancer, Lipids, and Metabolism
- Medication Adherence and Compliance
- Eicosanoids and Hypertension Pharmacology
- Pharmaceutical Economics and Policy
Which keywords describe Terry A. Jacobson's research?
The keywords of their largest research topics: Statins, Cardiovascular Disease Prevention, Cholesterol-lowering, LDL Cholesterol, Cardiovascular Disease, Cholesterol, Diabetes and Metabolic Syndrome.
- Epoxyeicosatrienoic Acids
- Arachidonic Acid
- Medication Adherence
- Fatty Acid Synthase
- Cost-effectiveness Analysis
- Dietary Intake
- Metabolic Syndrome
- Cholesterol
- LDL Cholesterol
- Cardiovascular Disease Prevention
- Statins
- Cholesterol-lowering
- Cardiovascular Disease
- Diabetes
- Inflammation
- Omega-3 Fatty Acids
- Quality of Life
- Lipid Metabolism
- Treatment Adherence
- Drug Development Costs
- Generic Drugs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Statins2142 topics
- Cardiovascular Disease Prevention2082 topics
- Cholesterol-lowering1841 topic
- LDL Cholesterol1841 topic
- Cardiovascular Disease1322 topics
- Cholesterol1112 topics
- Diabetes811 topic
- Metabolic Syndrome811 topic
- Inflammation722 topics
- Dietary Intake511 topic
- Omega-3 Fatty Acids511 topic
- Cost-effectiveness Analysis371 topic
- Quality of Life371 topic
- Fatty Acid Synthase301 topic
- Lipid Metabolism301 topic
- Medication Adherence241 topic
- Treatment Adherence241 topic
- Arachidonic Acid211 topic
- Drug Development Costs211 topic
- Epoxyeicosatrienoic Acids211 topic
- Generic Drugs211 topic
Where does Terry A. Jacobson work?
Terry A. Jacobson's main affiliation in the publication record is Emory University, United States.
How many publications and citations does Terry A. Jacobson have?
OpenAlex counts 299 works and 28,018 citations for Terry A. Jacobson, an h-index of 82, ranking #35,541 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Terry A. Jacobson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.